28-Day Repeat-Dose, Dose Escalation Study of 11-β Methyl Nortestosterone Dodecylcarbonate (11β-MNTDC) in Healthy Men
Clinical trial NCT03298373 · UNKNOWN
Trial details
- NCT number
- NCT03298373
- Sponsor
- Premier Research
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-09
- Primary completion
- 2019-02-05
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.